Stock Rich List
Nasdaq: ABUS

Arbutus Biopharma insiders

The officers, directors and 10% owners of Arbutus Biopharma Corporation who hold the most stock, valued at the live ABUS price.

$4.07
ABUS today −$40K (−0.97%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
4
Their ABUS stock
$135M
Market value
$624M
Held by ranked insiders
21.7%

Insiders by value of ABUS holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Matthew GlineDirector29,880,079$122M19.5%333rd
2Michael J. McElhaughInterim President & CEO1,658,003$6.7M1.08%11701st
3Michael J. SofiaChief Scientific Officer1,652,283$6.7M1.08%11733rd
4Keith ManchesterDirector46,069$188K<0.1%519th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Arbutus Biopharma; see each profile for the filing.